USAIC has created an ecosystem committed to driving a global dialogue on BioPharma & Healthcare innovation, attracting a diverse mix of senior industry professionals and catalyzing partnerships, new ideas, networks and regulatory reform. This unique platform creates mutually beneficial opportunities and relationships for the global Life Sciences & Healthcare industry.
Registration is closed
The Summit has reached full capacity. Registration is closed.
Thanks for your overwhelming response. See you at the 2025 summit!
18th Annual BioPharma & Healthcare Summit, Thursday, April 25, 2024: 8-15 AM - 6-15 PM
The Newbury Boston Hotel ,
One Newbury Street,
Boston, MA 02116,
USA
Emcee: Dr. Mathai Mammen, Chairman & CEO, FogPharma
Honoring Dr. Andy Plump, President of R&D, Takeda with the Distinguished Service Award. USAIC will be giving this award for the 4th time in 18 years.
Time
Topic
8-15 AM - 8-45 AM
Registration and Networking
8-45 AM - 8-55 AM
Welcome address : Karun Rishi, President, USAIC
Opening comments: Dr. Mathai Mammen , Chairman & CEO, FogPharma
8-55 AM - 9-40 AM
Panel Discussion: Clinical Trials Opportunities in India
Panelists:
Badhri Srinivasan , Head, Global Clinical Operations, Novartis
Dr. Christopher Corsico , Global Head of Development, GSK
Peyton Howell , Chief Operating & Growth Officer, Parexel
Dr. Sarah Sheikh , Head of Global Development, Takeda
Dr. Uli Broedl , SVP, Head of Global Clinical Development, Boehringer Ingelheim
Moderator:
Peter Ronco , Chief Executive Officer, Emmes
9-40 AM - 10-25 AM
Panel Discussion: Rare & Neuro Diseases
Panelists:
Dr. David Meeker , Chairman & CEO, Rhythm Pharmaceuticals
Dr. Ed Kaye , President & CEO, Stoke Therapeutics
Dr. James Wilson , Director- Gene Therapy Program, University of Pennsylvania
Josh Mandel-Brehm , President & CEO, CAMP4
Dr. Priya Singhal, Executive Vice President & Head of Development, Biogen Moderator:
Dr. Timothy Yu , Associate Professor in Paediatrics, Harvard Medical School
10-25 AM - 10-55 AM
Networking Break
10-55 AM - 11-25 AM
Fireside Chat (Hybrid)
Dr. Robert Califf , Commissioner of Food and Drugs, US Food and Drug Administration
Moderator:
Dr. William Chin , Professor of Medicine, Emeritus, Harvard Medical School
11-25 AM - 12-10 AM
Panel Discussion: BioPharma Industry & Investment Outlook
Panelists:
Christopher Viehbacher , President & CEO, Biogen
Dilip Shanghvi, Founder & Managing Director, Sun Pharmaceutical Industries
Hari Bhartia , Founder and Co-Chairman, Jubilant Bhartia Group
Rajiv Kaul, Sector Portfolio Manager, Fidelity Investments
Dr. Stelios Papadopoulos , Chairman of the Board, Exelixis
Moderator:
Daphne Zohar , Founder & Chief Executive Officer, Seaport Therapeutics
12-10 AM - 12-55 PM
Panel Discussion: Industry Academic Partnerships
Panelists:
Moderator:
Dr. Elias Zerhouni , Vice Chairman & President, OPKO Health
12-55 PM - 1-45 PM
Lunch
1-45 PM - 2-30 PM
Panel Discussion: Research & Development Strategies and Trends
Panelists:
Dr Andrew Plump , President of Research & Development, Takeda
Dr. Jane Grogan , Executive Vice President and Head of Research, Biogen
Dr. Mathai Mammen , Chairman & CEO, FogPharma
Dr. Robert Plenge , EVP, Chief Research Officer, Head of Research, Bristol Myers Squibb
Moderator:
Dr. Martin Mackay , Co-Founder, Rallybio
2-30 PM - 3-15 PM
Panel Discussion: Oncology
Panelists:
Dr. Alise Reicin , President & CEO, Tectonic Therapeutic
Dr. Bruce Chabner , Director of Clinical Research, Cancer Center, Mass General Hospital
Dr. Claire Mazumdar , Chief Executive Officer, Bicara Therapeutics
Phuong Khanh (P.K.) Morrow , Head of the Oncology Therapeutic Area Unit, Takeda
Dr. Zandy Forbes , President & CEO, MeiraGTx
Moderator:
Dr. Sam Waksal , Founder, Chairman & CEO, Graviton Biosciences
3-15 PM - 3-45 PM
Networking Break
3-45 PM - 4-30 pm
Panel Discussion: Digital & Data Science in Healthcare
Panelists:
Dr. Dina Katabi , Professor of Computer Science, MIT
Dr. Jason Kelly , Co-Founder & CEO, Ginkgo Bioworks
Dr. Krishna Yeshwant , Managing Partner, Google Ventures
Michael Nally , Chief Executive Officer, Generate:Biomedicines
Sastry Chilukuri , Chairman & CEO, Emmes Group
Moderator:
Dr. Najat Khan , Chief Data Science Officer, Johnson & Johnson Innovative Medicine
4-30 PM - 5-15 PM
Honouring Dr. Andrew Plump, President of Research & Development, Takeda with the Distinguished Service Award
5-15 PM - 6-15 PM
Networking Reception
*Program and Speakers subject to change